GAD2 and type 1 diabetes mellitus: Here we combined the superior performance of the magnICON® system with two edible plant species to develop a new platform for the large-scale production of GAD65 in plant tissue, in order to determine the feasibility of edible plants as a means to induce oral tolerance against T1D in preclinical and clinical studies.